Celgene Corporation

(CELG)

By |

Profile

Celgene Corp is a biopharmaceutical company. It is engaged in the discovery, development and commercialization of therapies designed to treat cancer and immune-inflammatory related diseases.

Contact Information

Website: www.celgene.com
Email: ir@celgene.com
Main Phone: +1 908 673-9000
Address: 86 Morris Avenue
State: NJ
City / Town: Summit
Country: USA
Postal Code: 07901

Issuer Information

Exchange: NGS
Employees: 6971
NAICS: Pharmaceutical P
$ 119.44 $ -1.72 (-1.42%)
Last Price 119.44 Change $ -1.72 Change % -1.42 Tick N/A
Bid 119.00 Bid Size 300.00 Ask 121.27 Ask Size 100.00
Open 121.39 High 122.22 Low 119.12 Prev Close 121.16
Last Trade Volume 4.6 mi 52 Wk Hi 127.00 52 Wk Low 94.39
Market Cap 92.9 bi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 777,966,471.00 EPS (TTM) 2.49 PE Ratio N/A Exchange NGS
  Last 3 Mo Last 12 Mo
Number of Insider Trades 25 87
Number of Buys 21 57
Number of Sells 4 30
Net Activity -85314 3588
Last 10 Buys Shares
Michael W. Bonney 1,000
Ernest Mario 1,000
Ernest Mario 1,000
Rodman L. Drake 1,000
Rodman L. Drake 1,000
James J. Loughlin 1,000
Jacqualyn A. Fouse 1,000
Rodman L. Drake 1,000
Rodman L. Drake 1,000
Rodman L. Drake 1,000
Last 10 Sell Shares
Michael D. Casey 1,000
Robert J. Hugin 1,000
Gilla Kaplan 1,000
James J. Loughlin 1,000
Ernest Mario 1,000
Michael D. Casey 1,000
Gilla Kaplan 1,000
Gilla Kaplan 1,000
Michael D. Casey 1,000
Thomas O. Daniel 1,000
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 162 162 162 162
Low Target Price Estimate 120 120 120 120
Mean Target Price Estimate 141.79 142.47 142.47 141.79
Standard Deviation 12.25 12.1 12.1 12.25
Date of Most Recent Estimate 08/15/16 08/09/16 07/29/16 08/19/16
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 14 14 13 13
Moderate Buy 0 0 1 1
Hold 3 3 3 3
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1.35 1.35 1.41 1.41